| 4BIO Ventures–SEVERAL: investment, 201909 first closing $50m of 4BIO Ventures II fund targeting $150m |
2019-09-09 |
| Lightcast Discovery–Instinctif Partners: public relations, 201909 service existent by Instinctif |
2019-09-09 |
| Lightcast Discovery–SEVERAL: investment, 201909 seed financing round £1.3m ($1.6m) from private investors |
2019-09-09 |
| ADC Therapeutics–SEVERAL: invvestment, 201909– IPO at NYSE filed |
2019-09-06 |
| iStar Medical–Belgium (govt): investment, 201909 financing round Series C totalling €40m incl existing + co-investor SFPI-FPIM |
2019-09-05 |
| iStar Medical–BNP Paribas: investment, 201909 financing round Series C totalling €40m incl new + co-investor BNP Paribas Fortis Private Equity |
2019-09-05 |
| iStar Medical–Capricorn Venture Partners: investment, 201909 financing round Series C totalling €40m incl existing + co-investor Capricorn |
2019-09-05 |
| iStar Medical–Earlybird: investment, 201909 financing round Series C totalling €40m incl new + co-investor Earlybird |
2019-09-05 |
| iStar Medical–Gimv: investment, 201909 financing round Series C totalling €40m incl new + co-lead investor Gimv |
2019-09-05 |
| iStar Medical–Life Sciences Partners: investment, 201909 financing round Series C totalling €40m incl new + co-lead investor LSP Health Economics 2 |
2019-09-05 |
| iStar Medical–Optimum Strategic Communications: public relations, 201909 service existent by Optimum |
2019-09-05 |
| iStar Medical–SEVERAL: investment, 201905 financing round Series C €40m led by LSP + Gimv |
2019-09-05 |
| iStar Medical–Wallonia (govt): investment, 201909 financing round Series C totalling €40m incl existing + co-investor SRIW |
2019-09-05 |
| Theragnostics–AstraZeneca: PARP inhibitors, 201909– license ww freedom to operate for developm of rPARPi as cancer theragnostic |
2019-09-05 |
| Theragnostics–Optimum Strategic Communications: public relations, 201909 service existent by Optimum |
2019-09-05 |
| TreeFrog Therapeutics–EU (govt): grant, 201909– Horizon 2022 SME Instrument Program Phase 2 Grant €2.4m |
2019-09-05 |
| TreeFrog Therapeutics–France (govt): grant, 201909–2020 grant €450k from Bpifrance i-Nov Innovation Challenge Phase 2 |
2019-09-05 |
| BioNTech–Gates Foundation: investment, 201909 equity investment $55m in connection with anti-infectives collaboration |
2019-09-04 |
| Curetis–OpGen: investment, 201909– reverse merger with Curetis shareholders holding 72.5% of combined entity |
2019-09-04 |
| Gates Foundation–BioNTech: anti-infectives, 201909– collab developm of HIV + TB immunotherapies with up to $100m funding incl equity investment $55m |
2019-09-04 |
| Uniqure–SEVERAL: investment, 201909– public offering $200m+$30m ANNOUNCED |
2019-09-04 |
| Achilles Therapeutics–Forbion: investment, 201909 financing round Series B totalling £100m incl new + co-investor Forbion |
2019-09-03 |
| Achilles Therapeutics–Invus Group: investment, 201909 financing round Series B totalling £100m incl new + co-investor Invus |
2019-09-03 |
| Achilles Therapeutics–Perceptive Advisors: investment, 201909 financing round Series B totalling £100m incl new + co-investor Perceptive Advisors |
2019-09-03 |
| Achilles Therapeutics–RA Capital Management: investment, 201909 financing round Series B totalling £100m incl new + lead investor RA Capital |
2019-09-03 |
| Achilles Therapeutics–Redmile Group: investment, 201909 financing round Series B totalling £100m incl new + co-investor Redmile Group |
2019-09-03 |
| Achilles Therapeutics–SEVERAL: investment, 201909 financing round Series B £100m led by RA Capital Management |
2019-09-03 |
| Achilles Therapeutics–Syncona: investment, 201909 financing round Series B totalling £100m incl existing + co-investor Syncona |
2019-09-03 |
| Univ College London–Bruker Corp: atomic force microscope, 201908 supply existent London Centre for Nanotechnology long-term user of NanoWizard systems |
2019-09-02 |
| GenomeWeb–Crain Communications: investment, 201909 acquisition of GenomeWeb LLC by Crain Communications Inc |
2019-09-01 |
| Kinomica–BioCity (GB): investment, 201908 investment by BioCity via Innovate UK Precision Medicine Investment Accelerator |
2019-08-29 |
| Celgene–Immatics: cell therapy, 201908– strategic collab + excl option $75m upfront + $1.5b milestones + royalties for three TCR-T targets |
2019-08-28 |
| HiFiBio–Delian Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Delian Capital |
2019-08-28 |
| HiFiBio–Gilead: investment, 201908 financing round Series C totalling $67m incl new + co-investor Kite |
2019-08-28 |
| HiFiBio–Hanne Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Hanne Capital |
2019-08-28 |
| HiFiBio–IDG Capital: investment, 201908 financing round Series C totalling $67m incl new + lead investor IDG Capital |
2019-08-28 |
| HiFiBio–Legend Star Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Legend Star Capital |
2019-08-28 |
| HiFiBio–Lyfe Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Lyfe Capital |
2019-08-28 |
| HiFiBio–Sequoia Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Sequoia Capital China |
2019-08-28 |
| HiFiBio–SEVERAL: investment, 201908 financing round Series C $67m led by new investor IDG Capital |
2019-08-28 |
| HiFiBio–VI Ventures: investment, 201908 financing round Series C totalling $67m incl existing + co-investor VI Ventures |
2019-08-28 |
| Protelux (RU)–Unibio: protein production from methane, 201908 collab existing buidling + operating plant for Uniprotein production in Russia |
2019-08-28 |
| Unibio–SEVERAL: investment, 201908 financing round $15m (£12.4m) from existing + new shareholders led by West Hill Capital |
2019-08-28 |
| Unibio–West Hill Capital: investment, 201908 financing round totalling $15m (£12.4m) incl lead investor West Hill Capital |
2019-08-28 |
| Adaptimmune–Noile-Immune: T cell therapy, 201908– collab up to $312m + royalties developm of SPEAR T-cell products using PRIME technology |
2019-08-27 |
| Spitality–Berlin (govt): investment, 201908 seed financing round from Capacura GmbH + VC Fonds Technologie Berlin |
2019-08-27 |
| Spitality–Capacura: investment, 201908 seed financing round from Capacura GmbH + VC Fonds Technologie Berlin |
2019-08-27 |
| Spitality–SEVERAL: investment, 201908 seed financing round from Capacura GmbH + VC Fonds Technologie Berlin to advance Krankenhaus.de |
2019-08-27 |
| Vaccitech–Scius Communications: public relations, 201908 supply service existent by Scius Communications |
2019-08-27 |
| ADC Therapeutics–Freenome: pharmacodiagnostics, 201908– collab developm multiomics biomarker for ADCT-402 treatment in DLBCL |
2019-08-26 |
| Univ Florence–Bruker Corp: NMR spectrometer, 201908– supply expected first customer for new 1.2 GHz NMR spectrometer |
2019-08-26 |
| AstraZeneca–FibroGen: roxadustat, 201908 collab existent commercialisation of roxadustat in China by AstraZeneca |
2019-08-22 |
| MDClone–aMoon: investment, 201908 financing round Series B totalling $26m incl lead investor aMoon |
2019-08-22 |
| MDClone–Lightspeed Venture Partners: investment, 201908 financing round Series B totalling $26m incl co.investor Lightspeed Venture Partners |
2019-08-22 |
| MDClone–Orbimed: investment, 201908 financing round Series B totalling $26m incl co.investor OrbiMed Israel Partners |
2019-08-22 |
| MDClone–SEVERAL: investment, 201908 financing round Series B $26m led by aMoon + incl OrbiMed + Lightspeed Venture Partners |
2019-08-22 |
| Merck (US)–Themis Bioscience: vaccine technology, 201908– collab research + license for use of MV technology platform for vaccine development |
2019-08-22 |
| Themis Bioscience–Merck (US): investment, 201908 equity investment €na by MSD as part of vaccine collaboration |
2019-08-22 |
| Oncorus–SEVERAL: investment, 201908 financing round Series B $79.5m co-led by Cowen Healthcare Investments + Perceptive Advisors |
2019-08-21 |
| Araris Biotech–Redalpine: investment, 201908 seed financing round totalling CHF2.5m incl investor Redalpine |
2019-08-20 |
| Araris Biotech–Schroders: investment, 201908 seed financing round totalling CHF2.5m incl investor Schroder Adveq |
2019-08-20 |
| Araris Biotech–SEVERAL: investment, 201908 seed financing round CHF2.5m with Redalpine + Schroder Adveq + VI Partners |
2019-08-20 |
| Araris Biotech–VI Partners: investment, 201908 seed financing round totalling CHF2.5m incl investor VI Partners |
2019-08-20 |
| Bayer–Elanco: investment, 201908– acquisition of Bayer Animal Health business for $5.3b in cash + $2.3b in shares |
2019-08-20 |
| Biotheus–Alligator Bioscience: therapeutic antibodies, 201908– license to Ab from Alligator-Gold library for bispecific molecules for Greater China |
2019-08-20 |
| Juvenescence–SEVERAL: investment, 201908 financing round Series B $100m incl founders + private investment companies |
2019-08-19 |
| AstronauTx–United Kingdom (govt): investment, 201908 investment £6.5m from Dementia Discovery Fund |
2019-08-13 |
| Synpromics–AskBio: investment, 201908 acquisition of Synpromics Ltd by Asklepios Biopharmaceutical Inc |
2019-08-13 |
| Boehringer–Univ Texas: cancer drugs, 201908– collab new virtual r+d center to advance new cancer therapies incl KRAS inhibitors + TRAILR2 agonists |
2019-08-12 |
| Cavion–Jazz Pharmaceuticals: investment, 201908 acquisition $52.5m upfront + $260m milestones of Cavion Inc by Jazz |
2019-08-12 |
| Curetis–HC Wainwright: investment banking, 201908– supply service Curetis retains HC Wainwright to evaluate all strategic options |
2019-08-12 |
| LemnaTec–Nynomic: investment, 201908 acquisition €na of assets of LemnaTec Gmbh by Nynomic AG |
2019-08-12 |
| BlueRock Therapeutics–Bayer: investment, 201808– acquisition 100% by acquiring remaining 59.2% for $240m upfront + $360m milestones |
2019-08-08 |
| a:head bio–red-stars.com data: investment, 201908– milestone-dependent 7-digit EUR seed investment by red-stars.com data AG in a:head bio AG |
2019-08-07 |
| MeiraGTx–SEVERAL: investment, 201908 public offering $75.2m+$11.28m with 3.2m+480k ordinary shares at $23.5/share |
2019-08-07 |
| Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC |
2019-08-06 |
| BSSN Software–Merck (DE): investment, 201908 acquisition €na of BSSN Software GmbH by Merck KGaA |
2019-08-06 |
| Fosanis–Ananda Ventures: investment, 201908 milllion Euro financing round from Ananda Impact Ventures + VC Fonds Technologie Berlin |
2019-08-06 |
| Fosanis–Berlin (govt): investment, 201908 milllion Euro financing round from Ananda Impact Ventures + VC Fonds Technologie Berlin |
2019-08-06 |
| Fosanis–SEVERAL: investment, 201908 milllion Euro financing round from Ananda Impact Ventures + VC Fonds Technologie Berlin to advance mika app |
2019-08-06 |
| Merck (DE)–BSSN Software: laboratory software, 2014– supply Merck working with BSSN Software |
2019-08-06 |
| Platomics–SEVERAL: investment, 201908 investment €7-digit from undisclosed investors |
2019-08-06 |
| Cytena–Cellink: investment, 201908 acquisition €30.25m of Cytena GmbH by Cellink AB |
2019-08-05 |
| GNA Biosolutions–Bavaria (govt): investment, 201908 financing round Series C totalling $13.5m incl new investor Wachstumsfonds Bayern |
2019-08-05 |
| GNA Biosolutions–Bosch: investment, 201908 financing round Series C totalling $13.5m incl existing investor Robert Bosch Venture Capital |
2019-08-05 |
| GNA Biosolutions–btov Partners: investment, 201908 financing round Series C totalling $13.5m incl existing investor btov Partners |
2019-08-05 |
| GNA Biosolutions–Germany (govt): investment, 201908 financing round Series C totalling $13.5m incl existing investor KfW |
2019-08-05 |
| GNA Biosolutions–GreyBird Ventures: investment, 201908 financing round Series C totalling $13.5m incl new investor GreyBird Ventures |
2019-08-05 |
| GNA Biosolutions–Mey Capital Matrix: investment, 201908 financing round Series C totalling $13.5m incl existing investor Mey Capital Matrix |
2019-08-05 |
| GNA Biosolutions–Occident Group: investment, 201908 financing round Series C totalling $13.5m incl new investor Occident |
2019-08-05 |
| GNA Biosolutions–SEVERAL: investment, 201908 financing round Series C $13.5m from new + existing EU + US investors |
2019-08-05 |
| GNA Biosolutions–SHS: investment, 201908 financing round Series C totalling $13.5m incl existing investor SHS Gesellschaft für Beteiligungsmanagement |
2019-08-05 |
| GNA Biosolutions–UVC Partners: investment, 201908 financing round Series C totalling $13.5m incl existing investor UVC Partners |
2019-08-05 |
| Imcyse–Andrew Lloyd Associates: public relations, 201908 service existent by ALA |
2019-08-05 |
| Inveox–SEVERAL: investment, 201908 3rd financing round €17m |
2019-08-05 |
| Alizé Pharma–SEVERAL: investment, 201907 financing round Series A €67m of Alizé Pharma 3 led by LSP |
2019-07-31 |
| Atlantic Healthcare–Consilium: public relations, 201907 service existent European IR + media relations by CSC |
2019-07-31 |
| Atlantic Healthcare–Lazar Partners: public relations, 201907 service existent US IR + media relations by Lazar Partners |
2019-07-31 |
| Wellington Partners–Consilium: public relations, 201907 service existent by CSC |
2019-07-31 |
| Wellington Partners–EU (govt): investment, 201907 final closing totalling €210m WPLS-V fund incl exisiting investor EIB/EIF |
2019-07-31 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
Date![[iito] Business Intelligence – The Elephants Are Coming 560x91px](/banner/iito-20190816-650-091-youtube-video-the-elephants-are-coming-telegram.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
